Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure

@article{Harch2020HyperbaricOT,  title={Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure},  author={Paul G Harch},  journal={Medical Gas Research},  year={2020},  volume={10},  pages={61 - 62},  url={https://api.semanticscholar.org/CorpusID:216380932}}
The authors suggested that HBOT applied earlier in the disease process would prevent the deterioration that leads to the significant morbidity and mortality of COVID-19 infection.

Figures from this paper

42 Citations

The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19

The inclusion of daily sessions of hyperbaric oxygenation in "soft" modes (1 4-1 6 ATA) in the complex therapy for COVID-19 has shown its safety and preliminary positive effect on the subjective state of the examined patients and the dynamics of blood oxygen saturation.

Hyperbaric oxygen therapy: Can it be a novel supportive therapy in COVID-19?

Hyperbaric oxygen therapy (HBOT) has been proposed as a supportive strategy to improve oxygenation in COVID-19 patients because it is known to increase tissue oxygenation by increasing the amount of dissolved oxygen in plasma and mitigates tissue inflammation thus reducing the ill effects of cytokine storm.

Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a narrative review.

The Coronavirus illness 2019 (COVID-19) was first observed to induce fever, dry cough, pneumonia, and dyspnea in the lower respiratory tract, and hyperbaric oxygen treatment (HBOT) is thought to boost tissue oxygenation by increasing plasma soluble oxygen levels.

Hyperbaric oxygenation therapy for treating complicated COVID-19: first experience

Highly virulent SARS-CoV-2 emerged in Wuhan, China, and rapidly spread across the globe afflicting 14.5 million and killing over 600,000 people. The key factors affecting the severity of COVID-19…

Hyperbaric Oxygen Therapy in Patients with COVID-19

Hyperbaric oxygen therapy in patients with new coronavirus infection caused by the SARS-CoV-2 virus is an effective treatment method with multiple effects resulting in improvement of subjective indicators of the patients' condition, increase of hemoglobin oxygen saturation, decrease of lipid peroxidation intensity, activation of antioxidant system, restoration of pro- and antioxidant balance and apoptosis normalization.

Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial

Oxygenation and anti-inflammatory effects of Hyperbaric Oxygen Therapy (HBOT) suggest that it is a promising adjunct treatment for COVID-19 and indicated HBOT can lead to alleviation of inflammation and partial restoration of T cell responses.

Hyperbaric Oxygen Treatment for Long COVID: From Molecular Mechanism to Clinical Practice

It is believed that HBOT is an effective option for patients with long COVID, which is worth actively promoting.

Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review

Medical ozone rationale in COVID-19 is the possibility of contrasting endothelial dysfunction, modulating the immune response and acting as a virustatic agent, which could help to decrease lung inflammation, slow down viral growth, regulate lung circulation and oxygenation and prevent microvascular thrombosis.

Hyperbaric oxygen therapy in rehabilitation of patients after COVID‑19

The inclusion in the rehabilitation of COVID‑19 patients of daily sessions of hyperbaric oxygenation in ‘soft’ modes (1,4–1,6 ATA) in combination with respiratory and physical gymnastics showed a positive effect and safety, and in patients, shortness of breath decreased, blood saturation indicators improved, cognitive functions decreased, the severity of anxiety and depression decreased, and exercise tolerance increased.

Hyperbaric Oxygen Therapy for ‘Happy’ Hypoxia in COVID-19 Patient, Why is it Better?

Reports from various Hyperbaric Centres in China and the USA show promising results in using HBOT to overcome the respiratory failure in COVID-19 due to its various properties and with ongoing RCTs, it is hoped that it will give satisfactory results so that it can help overcome hypoxia in CO VID-19 patients.

4 References

Acute respiratory distress syndrome in patients after blunt thoracic trauma: the influence of hyperbaric oxygen therapy.

It is reasonable to conclude that the prevention and correction of oxygen deficiency are basic to intensive care during ARDS.

Textbook of Hyperbaric Medicine

Part 1 Basic aspects: history of hyperbaric medicine physical, physiological and biochemical aspects of hyperbaric oxygenation effect of diving and high pressure environments on the human body…

Related Papers

Showing 1 through 3 of 0 Related Papers